{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"megdel","columns":[{"gene":"","key":"population-22026863479bf505570d","label":"3-Methylglutaconic aciduria with deafness, encephalopathy, and leigh-like syndrome","mondoId":"MONDO:0013875","onsetQualifier":null,"originColumnKey":"MONDO:0013875/OMIM:614739","originalViews":[{"key":"MONDO:0013875/OMIM:614739","label":"3-Methylglutaconic aciduria with deafness, encephalopathy, and leigh-like syndrome","scopeLabel":"OMIM:614739","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0850607722fb19d670182bb615070fe53c52857f14845755a3d515f902928e0e","14b705a82f75f44d75e070232d1a8a7e1390bd1dfdc2b7d90848b87d3928b297","152d76142ca3499413020e5188c8541a6d2441f3239907ae4cacce4620e0e832","19ec4afe6a4278787f2e1271cecef53564f6cf9f51b7cad3e19bcc18531e4b27","25f990af805c6c10f4f453ab9836fd51a0bf5e4eb8db45d4837ab7e5e5875fdc","2d20ef3c3eb3e9aa842a70b221739a65c44d316b312765b929487a627cbe8136","33f517921663e180949888db5e4212f5ff21c74dead4cc7005073e585ff7d166","3afdabb39bd7cca4c2ac57fa8497c904cfb0e5071f59bb76ef1c9cc6e629fdd3","4020baa86abdb5d2b68b8c95e64eabda4fc8ff65c1dd1c18119910fbec678f81","55b6ad353f6e5065946bbcdeb38d27de80ca77fa6619aac34fd96e2967d33648","5758fd3f332c55cf88d6ea233248a092ff0c02cc991daae5ba0006de2b702002","6831f8bb43c6e29ba73a03dafa73511ffb2c3f125453f4dad3e89bdd5768daf4","6e617d56fe55d30336d6c6f486be81fd47ff1f3a9d290bf5036b65ba40c08b0e","7fdccce2b7f58dd4d003ebbbb3b4fa72792eeab71e48a5a977b87f677276cf43","881f2b8dea56286b30a6836619d6fd54795e15c59591b16132eaf7648546a24b","8f240348d4b8e54d56c51466e97956557eb8dfdf3cda2a52c635b172c3fcb55a","a3e805ade4ccc54af2f9834cd9e528eac46535f6a0c122696e7f2b83508e1721","a4d6a82ec6339fc7073eca7b99c583c45278427cc3a740dfe03e91a25f4ab46e","a6825b48c3c32011c57c40e7e68ba6bbc0d46e0976787e824474a10a778ba484","ae72ea7d86e0a05f1231e182ac8d3cf78d7c968a451cfcb80757b3a0b5f00f3f","beb252ffae4f4b04adc7adef91b1500075f344352e5caf8422def708239b4280","d1a2a41420b8d47f6d2afaa56eae77fac6b32bb3b20d024267e325d73d207bd0","d40da3f492f85d737004b401c268a77898c5d349d852a0e5a44990567e34c021","db046b06c072a951533e4115cd42ec7b95a6d593d1a2e997f39af2c611392084","e1bc579989899c6511413515b485a0427cb405e466b2dae5597e7c0324233c26","ea7b4ff397bec30fb4d1998ed7f26955e1c4bc382800304f47479b4f5a1d2609","ee84a657b29c829bdf7908faaf6e1648444105b1e8095d1a76b1bc5240506924","ef9089109b6a7125920d262413fd6cdffba577552bcd657050a9dcbffae09562","f12dadf661ff6b7de5051ad3309b62f57f7b6211a7a48484da027c1d50f720b4","f928e218bf36277ee04b205b625baede44128ae077f53838fa2dd119e21a67dd"],"recordQualifiers":{},"scopeLabel":"OMIM:614739","sourceIds":["OMIM:614739"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-22026863479bf505570d"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0003535","HP:0002071","HP:0003256","HP:0001344","HP:0002977","HP:0012444","HP:0001272"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":11,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":30,"sourceGroups":{"omim":21,"published":9}},"features":[{"hpoId":"HP:0003535","label":"3-Methylglutaconic aciduria","primary":true},{"hpoId":"HP:0002071","label":"Abnormality of extrapyramidal motor function","primary":true},{"hpoId":"HP:0003256","label":"Abnormality of the coagulation cascade","primary":true},{"hpoId":"HP:0001344","label":"Absent speech","primary":true},{"hpoId":"HP:0002977","label":"Aplasia/Hypoplasia involving the central nervous system","primary":true},{"hpoId":"HP:0012444","label":"Brain atrophy","primary":true},{"hpoId":"HP:0001272","label":"Cerebellar atrophy","primary":true},{"hpoId":"HP:0002376","label":"Developmental regression","primary":false},{"hpoId":"HP:0001332","label":"Dystonia","primary":false},{"hpoId":"HP:0001298","label":"Encephalopathy","primary":false},{"hpoId":"HP:0001508","label":"Failure to thrive","primary":false},{"hpoId":"HP:0011968","label":"Feeding difficulties","primary":false},{"hpoId":"HP:0001290","label":"Generalized hypotonia","primary":false},{"hpoId":"HP:0001263","label":"Global developmental delay","primary":false},{"hpoId":"HP:0003348","label":"Hyperalaninemia","primary":false},{"hpoId":"HP:0001987","label":"Hyperammonemia","primary":false},{"hpoId":"HP:0001943","label":"Hypoglycemia","primary":false},{"hpoId":"HP:0001252","label":"Hypotonia","primary":false},{"hpoId":"HP:0002540","label":"Inability to walk","primary":false},{"hpoId":"HP:0002151","label":"Increased circulating lactate concentration","primary":false},{"hpoId":"HP:0001249","label":"Intellectual disability","primary":false},{"hpoId":"HP:0003128","label":"Lactic acidosis","primary":false},{"hpoId":"HP:0000252","label":"Microcephaly","primary":false},{"hpoId":"HP:0040187","label":"Neonatal sepsis","primary":false},{"hpoId":"HP:0000648","label":"Optic atrophy","primary":false},{"hpoId":"HP:6001454","label":"Putaminal eye sign","primary":false},{"hpoId":"HP:0002719","label":"Recurrent infections","primary":false},{"hpoId":"HP:0001250","label":"Seizure","primary":false},{"hpoId":"HP:0000407","label":"Sensorineural hearing impairment","primary":false},{"hpoId":"HP:0001257","label":"Spasticity","primary":false}],"ledeHtml":"MEGDEL syndrome is an inherited disorder that affects multiple body systems. It is named for several of its features: 3-methylglutaconic aciduria (MEG), deafness (D), encephalopathy (E), and Leigh-like disease (L). MEGDEL syndrome is characterized by abnormally high levels of an acid, called 3-methylglutaconic acid, in the urine (3-methylglutaconic aciduria). MEGDEL syndrome is one of a group of metabolic disorders that can be diagnosed by presence of this feature. People with MEGDEL syndrome also have high urine levels of another acid called 3-methylglutaric acid. In infancy, individuals with MEGDEL syndrome develop hearing loss caused by changes in the inner ear (sensorineural deafness); the hearing problems gradually worsen over time. Another feature of MEGDEL syndrome is brain dysfunction (encephalopathy). In infancy, encephalopathy leads to difficulty feeding, an inability to grow and gain weight at the expected rate (failure to thrive), and weak muscle tone (hypotonia). Infants with MEGDEL syndrome later develop involuntary muscle tensing (dystonia) and muscle stiffness (spasticity), which worsen over time. Because of these brain and muscle problems, affected babies have delayed development of mental and movement abilities (psychomotor delay), or they may lose skills they already developed. Individuals with MEGDEL syndrome have intellectual disability and never learn to speak. People with MEGDEL syndrome have changes in the brain that resemble those in another condition called Leigh syndrome. These changes, which can be seen with medical imaging, are referred to as Leigh-like disease. Other features that occur commonly in MEGDEL syndrome include low blood glucose (hypoglycemia) in affected newborns; liver problems (hepatopathy) in infancy, which can be serious but improve by early childhood; and episodes of abnormally high amounts of lactic acid in the blood (lactic acidosis). The life expectancy of individuals with MEGDEL syndrome is unknown. Because of the severe health problems caused by the disorder, some affected individuals do not survive past infancy.","mondoId":"MONDO:0013875","node":{"canonicalSlug":"megdel","comparisons":[{"documentSha256":"e3c429ef5a8d4357daa33aaa1d0f8187681f3c61c761476cd68acc8fcdb8cb4f","key":"legacy-megdel","kind":"legacy","label":"3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome","memberIds":["MONDO:0013875"],"mondoId":"MONDO:0013875","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/megdel.e3c429ef5a8d4357daa33aaa1d0f8187681f3c61c761476cd68acc8fcdb8cb4f.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome","originalSourceId":"ORPHA:352328","paragraphs":["MEGDEL syndrome is an inherited disorder that affects multiple body systems. It is named for several of its features: 3-methylglutaconic aciduria (MEG), deafness (D), encephalopathy (E), and Leigh-like disease (L). MEGDEL syndrome is characterized by abnormally high levels of an acid, called 3-methylglutaconic acid, in the urine (3-methylglutaconic aciduria). MEGDEL syndrome is one of a group of metabolic disorders that can be diagnosed by presence of this feature. People with MEGDEL syndrome also have high urine levels of another acid called 3-methylglutaric acid. In infancy, individuals with MEGDEL syndrome develop hearing loss caused by changes in the inner ear (sensorineural deafness); the hearing problems gradually worsen over time. Another feature of MEGDEL syndrome is brain dysfunction (encephalopathy). In infancy, encephalopathy leads to difficulty feeding, an inability to grow and gain weight at the expected rate (failure to thrive), and weak muscle tone (hypotonia). Infants with MEGDEL syndrome later develop involuntary muscle tensing (dystonia) and muscle stiffness (spasticity), which worsen over time. Because of these brain and muscle problems, affected babies have delayed development of mental and movement abilities (psychomotor delay), or they may lose skills they already developed. Individuals with MEGDEL syndrome have intellectual disability and never learn to speak. People with MEGDEL syndrome have changes in the brain that resemble those in another condition called Leigh syndrome. These changes, which can be seen with medical imaging, are referred to as Leigh-like disease. Other features that occur commonly in MEGDEL syndrome include low blood glucose (hypoglycemia) in affected newborns; liver problems (hepatopathy) in infancy, which can be serious but improve by early childhood; and episodes of abnormally high amounts of lactic acid in the blood (lactic acidosis). The life expectancy of individuals with MEGDEL syndrome is unknown. Because of the severe health problems caused by the disorder, some affected individuals do not survive past infancy."],"rawAttribution":"MONDO:0013875","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:00:14Z","upstream":"MONDO:0013875","url":"https://rarediseases.info.nih.gov/diseases/12963"},"ownColumnKeys":["population-22026863479bf505570d"],"publication":"published","relationships":[{"kind":"parent","label":"inborn mitochondrial metabolism disorder","mondoId":"MONDO:0004069","slug":"inborn-mitochondrial-metabolism-disorder"},{"kind":"parent","label":"3-methylglutaconic aciduria","mondoId":"MONDO:0017359","slug":"3-methylglutaconic-aciduria"},{"kind":"parent","label":"disorder of phospholipids, sphingolipids and fatty acids biosynthesis","mondoId":"MONDO:0018117","slug":null},{"kind":"parent","label":"SERAC1-related neurological disorder","mondoId":"MONDO:0100548","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"synonym-scope-not-retained","source":"MedlinePlus","url":"https://medlineplus.gov/genetics/condition/megdel-syndrome"}],"translation":"pending"},"records":[{"frequencyKind":"range","key":"0850607722fb19d670182bb615070fe53c52857f14845755a3d515f902928e0e","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:614739","disease_name":"3-Methylglutaconic aciduria with deafness, encephalopathy, and leigh-like syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"OMIM:614739","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"14b705a82f75f44d75e070232d1a8a7e1390bd1dfdc2b7d90848b87d3928b297","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:614739","disease_name":"3-Methylglutaconic aciduria with deafness, encephalopathy, and leigh-like syndrome","evidence":"TAS","frequency_raw":"14/15","hpo_id":"HP:0002151","is_excluded":false,"label":"Increased circulating lactate concentration","onset_id":null,"reference":"OMIM:614739","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"152d76142ca3499413020e5188c8541a6d2441f3239907ae4cacce4620e0e832","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:614739","disease_name":"3-Methylglutaconic aciduria with deafness, encephalopathy, and leigh-like syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001298","is_excluded":false,"label":"Encephalopathy","onset_id":null,"reference":"OMIM:614739","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"19ec4afe6a4278787f2e1271cecef53564f6cf9f51b7cad3e19bcc18531e4b27","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:614739","disease_name":"3-Methylglutaconic aciduria with deafness, encephalopathy, and leigh-like syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001987","is_excluded":false,"label":"Hyperammonemia","onset_id":null,"reference":"OMIM:614739","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"25f990af805c6c10f4f453ab9836fd51a0bf5e4eb8db45d4837ab7e5e5875fdc","raw":{"aspect":"P","body_system":"ear","disease_id":"OMIM:614739","disease_name":"3-Methylglutaconic aciduria with deafness, encephalopathy, and leigh-like syndrome","evidence":"PCS","frequency_raw":"13/14","hpo_id":"HP:0000407","is_excluded":false,"label":"Sensorineural hearing impairment","onset_id":null,"reference":"PMID:22683713","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"2d20ef3c3eb3e9aa842a70b221739a65c44d316b312765b929487a627cbe8136","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:614739","disease_name":"3-Methylglutaconic aciduria with deafness, encephalopathy, and leigh-like syndrome","evidence":"PCS","frequency_raw":"15/15","hpo_id":"HP:0002376","is_excluded":false,"label":"Developmental regression","onset_id":null,"reference":"PMID:22683713","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"33f517921663e180949888db5e4212f5ff21c74dead4cc7005073e585ff7d166","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:614739","disease_name":"3-Methylglutaconic aciduria with deafness, encephalopathy, and leigh-like syndrome","evidence":"PCS","frequency_raw":"8/11","hpo_id":"HP:0012444","is_excluded":false,"label":"Brain atrophy","onset_id":null,"reference":"PMID:22683713","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"3afdabb39bd7cca4c2ac57fa8497c904cfb0e5071f59bb76ef1c9cc6e629fdd3","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:614739","disease_name":"3-Methylglutaconic aciduria with deafness, encephalopathy, and leigh-like syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001252","is_excluded":false,"label":"Hypotonia","onset_id":null,"reference":"OMIM:614739","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"4020baa86abdb5d2b68b8c95e64eabda4fc8ff65c1dd1c18119910fbec678f81","raw":{"aspect":"P","body_system":"digestive","disease_id":"OMIM:614739","disease_name":"3-Methylglutaconic aciduria with deafness, encephalopathy, and leigh-like syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0011968","is_excluded":false,"label":"Feeding difficulties","onset_id":null,"reference":"OMIM:614739","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"55b6ad353f6e5065946bbcdeb38d27de80ca77fa6619aac34fd96e2967d33648","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:614739","disease_name":"3-Methylglutaconic aciduria with deafness, encephalopathy, and leigh-like syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002977","is_excluded":false,"label":"Aplasia/Hypoplasia involving the central nervous system","onset_id":null,"reference":"OMIM:614739","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"5758fd3f332c55cf88d6ea233248a092ff0c02cc991daae5ba0006de2b702002","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:614739","disease_name":"3-Methylglutaconic aciduria with deafness, encephalopathy, and leigh-like syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003128","is_excluded":false,"label":"Lactic acidosis","onset_id":null,"reference":"OMIM:614739","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"6831f8bb43c6e29ba73a03dafa73511ffb2c3f125453f4dad3e89bdd5768daf4","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:614739","disease_name":"3-Methylglutaconic aciduria with deafness, encephalopathy, and leigh-like syndrome","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000252","is_excluded":false,"label":"Microcephaly","onset_id":null,"reference":"OMIM:614739","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"6e617d56fe55d30336d6c6f486be81fd47ff1f3a9d290bf5036b65ba40c08b0e","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:614739","disease_name":"3-Methylglutaconic aciduria with deafness, encephalopathy, and leigh-like syndrome","evidence":"PCS","frequency_raw":"30/30","hpo_id":"HP:6001454","is_excluded":false,"label":"Putaminal eye sign","onset_id":null,"reference":"PMID:25642805","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"7fdccce2b7f58dd4d003ebbbb3b4fa72792eeab71e48a5a977b87f677276cf43","raw":{"aspect":"P","body_system":"blood","disease_id":"OMIM:614739","disease_name":"3-Methylglutaconic aciduria with deafness, encephalopathy, and leigh-like syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0003256","is_excluded":false,"label":"Abnormality of the coagulation cascade","onset_id":null,"reference":"OMIM:614739","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"881f2b8dea56286b30a6836619d6fd54795e15c59591b16132eaf7648546a24b","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:614739","disease_name":"3-Methylglutaconic aciduria with deafness, encephalopathy, and leigh-like syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0040187","is_excluded":false,"label":"Neonatal sepsis","onset_id":null,"reference":"OMIM:614739","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"8f240348d4b8e54d56c51466e97956557eb8dfdf3cda2a52c635b172c3fcb55a","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:614739","disease_name":"3-Methylglutaconic aciduria with deafness, encephalopathy, and leigh-like syndrome","evidence":"PCS","frequency_raw":"8/13","hpo_id":"HP:0003348","is_excluded":false,"label":"Hyperalaninemia","onset_id":null,"reference":"PMID:22683713","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"a3e805ade4ccc54af2f9834cd9e528eac46535f6a0c122696e7f2b83508e1721","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:614739","disease_name":"3-Methylglutaconic aciduria with deafness, encephalopathy, and leigh-like syndrome","evidence":"TAS","frequency_raw":"14/14","hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"OMIM:614739","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"a4d6a82ec6339fc7073eca7b99c583c45278427cc3a740dfe03e91a25f4ab46e","raw":{"aspect":"P","body_system":"immune","disease_id":"OMIM:614739","disease_name":"3-Methylglutaconic aciduria with deafness, encephalopathy, and leigh-like syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002719","is_excluded":false,"label":"Recurrent infections","onset_id":null,"reference":"OMIM:614739","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"a6825b48c3c32011c57c40e7e68ba6bbc0d46e0976787e824474a10a778ba484","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:614739","disease_name":"3-Methylglutaconic aciduria with deafness, encephalopathy, and leigh-like syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001508","is_excluded":false,"label":"Failure to thrive","onset_id":null,"reference":"OMIM:614739","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"ae72ea7d86e0a05f1231e182ac8d3cf78d7c968a451cfcb80757b3a0b5f00f3f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:614739","disease_name":"3-Methylglutaconic aciduria with deafness, encephalopathy, and leigh-like syndrome","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0002540","is_excluded":false,"label":"Inability to walk","onset_id":null,"reference":"OMIM:614739","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"beb252ffae4f4b04adc7adef91b1500075f344352e5caf8422def708239b4280","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:614739","disease_name":"3-Methylglutaconic aciduria with deafness, encephalopathy, and leigh-like syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001943","is_excluded":false,"label":"Hypoglycemia","onset_id":null,"reference":"OMIM:614739","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"d1a2a41420b8d47f6d2afaa56eae77fac6b32bb3b20d024267e325d73d207bd0","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:614739","disease_name":"3-Methylglutaconic aciduria with deafness, encephalopathy, and leigh-like syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001272","is_excluded":false,"label":"Cerebellar atrophy","onset_id":null,"reference":"OMIM:614739","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"d40da3f492f85d737004b401c268a77898c5d349d852a0e5a44990567e34c021","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:614739","disease_name":"3-Methylglutaconic aciduria with deafness, encephalopathy, and leigh-like syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002071","is_excluded":false,"label":"Abnormality of extrapyramidal motor function","onset_id":null,"reference":"OMIM:614739","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"db046b06c072a951533e4115cd42ec7b95a6d593d1a2e997f39af2c611392084","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:614739","disease_name":"3-Methylglutaconic aciduria with deafness, encephalopathy, and leigh-like syndrome","evidence":"PCS","frequency_raw":"14/14","hpo_id":"HP:0001332","is_excluded":false,"label":"Dystonia","onset_id":null,"reference":"PMID:22683713","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"e1bc579989899c6511413515b485a0427cb405e466b2dae5597e7c0324233c26","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:614739","disease_name":"3-Methylglutaconic aciduria with deafness, encephalopathy, and leigh-like syndrome","evidence":"PCS","frequency_raw":"13/14","hpo_id":"HP:0001257","is_excluded":false,"label":"Spasticity","onset_id":null,"reference":"PMID:22683713","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"ea7b4ff397bec30fb4d1998ed7f26955e1c4bc382800304f47479b4f5a1d2609","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:614739","disease_name":"3-Methylglutaconic aciduria with deafness, encephalopathy, and leigh-like syndrome","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001344","is_excluded":false,"label":"Absent speech","onset_id":null,"reference":"OMIM:614739","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"ee84a657b29c829bdf7908faaf6e1648444105b1e8095d1a76b1bc5240506924","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:614739","disease_name":"3-Methylglutaconic aciduria with deafness, encephalopathy, and leigh-like syndrome","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001290","is_excluded":false,"label":"Generalized hypotonia","onset_id":null,"reference":"OMIM:614739","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"ef9089109b6a7125920d262413fd6cdffba577552bcd657050a9dcbffae09562","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:614739","disease_name":"3-Methylglutaconic aciduria with deafness, encephalopathy, and leigh-like syndrome","evidence":"PCS","frequency_raw":"14/14","hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"PMID:22683713","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"f12dadf661ff6b7de5051ad3309b62f57f7b6211a7a48484da027c1d50f720b4","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:614739","disease_name":"3-Methylglutaconic aciduria with deafness, encephalopathy, and leigh-like syndrome","evidence":"PCS","frequency_raw":"14/14","hpo_id":"HP:0003535","is_excluded":false,"label":"3-Methylglutaconic aciduria","onset_id":null,"reference":"PMID:22683713","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"f928e218bf36277ee04b205b625baede44128ae077f53838fa2dd119e21a67dd","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:614739","disease_name":"3-Methylglutaconic aciduria with deafness, encephalopathy, and leigh-like syndrome","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0000648","is_excluded":false,"label":"Optic atrophy","onset_id":null,"reference":"OMIM:614739","source_release":"2026-06-23"},"sourceGroups":["omim"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/12963\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0013875\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0013875</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>MEGDEL syndrome is an inherited disorder that affects multiple body systems. It is named for several of its features: 3-methylglutaconic aciduria (MEG), deafness (D), encephalopathy (E), and Leigh-like disease (L). MEGDEL syndrome is characterized by abnormally high levels of an acid, called 3-methylglutaconic acid, in the urine (3-methylglutaconic aciduria). MEGDEL syndrome is one of a group of metabolic disorders that can be diagnosed by presence of this feature. People with MEGDEL syndrome also have high urine levels of another acid called 3-methylglutaric acid. In infancy, individuals with MEGDEL syndrome develop hearing loss caused by changes in the inner ear (sensorineural deafness); the hearing problems gradually worsen over time. Another feature of MEGDEL syndrome is brain dysfunction (encephalopathy). In infancy, encephalopathy leads to difficulty feeding, an inability to grow and gain weight at the expected rate (failure to thrive), and weak muscle tone (hypotonia). Infants with MEGDEL syndrome later develop involuntary muscle tensing (dystonia) and muscle stiffness (spasticity), which worsen over time. Because of these brain and muscle problems, affected babies have delayed development of mental and movement abilities (psychomotor delay), or they may lose skills they already developed. Individuals with MEGDEL syndrome have intellectual disability and never learn to speak. People with MEGDEL syndrome have changes in the brain that resemble those in another condition called Leigh syndrome. These changes, which can be seen with medical imaging, are referred to as Leigh-like disease. Other features that occur commonly in MEGDEL syndrome include low blood glucose (hypoglycemia) in affected newborns; liver problems (hepatopathy) in infancy, which can be serious but improve by early childhood; and episodes of abnormally high amounts of lactic acid in the blood (lactic acidosis). The life expectancy of individuals with MEGDEL syndrome is unknown. Because of the severe health problems caused by the disorder, some affected individuals do not survive past infancy.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/12963\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"megdel","sourceDocuments":[{"name":"GARD: 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome","reviewed":null,"source_release":"2026-10-21T17:00:14Z","url":"https://rarediseases.info.nih.gov/diseases/12963"},{"name":"MONDO: 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0013875"}],"sourceNote":"","synonyms":["3-methylglutaconic aciduria caused by mutation in SERAC1","3-methylglutaconic aciduria type VI","3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome","3-methylglutaconic aciduria with deafness-encephalopathy-Leigh-like syndrome","3-MGCA type IV (formerly)","3-MGCA-4 (formerly)","MEGDEL","MEGDEL syndrome","MGCA6","SERAC1 3-methylglutaconic aciduria","SERAC1 defect"],"takeawayHtml":"","title":"3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome"},"schemaVersion":1}
